onshoring trend
Search documents
Jim Cramer on Chipotle Mexican Grill: “It’s Got to Show Some Better-Than-Expected Numbers, and It Hasn’t Been Able to Do That Yet”
Yahoo Finance· 2026-03-31 16:36
Core Insights - Jim Cramer provided insights on Chipotle Mexican Grill, emphasizing the need for the company to deliver better-than-expected financial results in the upcoming quarter [1][3] Company Performance - Chipotle Mexican Grill operates restaurants offering a variety of menu items including burritos, bowls, tacos, and salads [3] - The stock has been trading around $34 to $35 since its last report, indicating a period of stagnation [3] - Cramer expressed optimism about the company's future performance but noted that the restaurant sector is under pressure due to rising gasoline prices, which negatively impacts restaurant sales [3] Market Context - The company is currently viewed as being in a challenging position, referred to as the "house of pain," which reflects the difficulties faced in the market [3] - Despite the challenges, there is a belief that the financial numbers for Chipotle will improve in the near future [3]
Meta Platforms (META) to Lay off a Few Hundred Employees
Yahoo Finance· 2026-03-31 14:43
Core Insights - Meta Platforms, Inc. is expected to lay off a few hundred employees across various teams, which is a smaller scale compared to earlier reports suggesting layoffs could affect around 20% or more of the total workforce [1][2] - The layoffs are part of a structural change aimed at positioning the company to achieve its goals and offset rising costs, with projected spending of approximately $162 billion to $169 billion by 2026 [4] - As of December 31, the company had around 79,000 employees, indicating the scale of the workforce impacted by these changes [4] Company Overview - Meta Platforms, Inc. is a California-based company that develops social media applications, focusing on connecting people and growing businesses [5] - The company operates through two segments: Family of Apps (FoA) and Reality Labs (RL) [5]
Solventum (SOLV) Rated Buy by Jefferies After Earnings Beat
Yahoo Finance· 2026-03-31 08:36
Solventum Corporation (NYSE:SOLV) ranks among the recent spin-off companies that hedge funds are piling into. On March 20, CIBC reiterated its Outperformer rating on Solventum Corporation (NYSE:SOLV) and its $37 price target. The firm believes the company’s 2026 forecast, which is slightly higher than consensus estimates, includes some caution, notably on gross margins. CIBC stated that management might use increased balance sheet capacity for mergers and acquisitions to increase scale, footprint, and se ...
Jefferies Bullish on The Home Depot (HD) Following Mingledorff Acquisition
Yahoo Finance· 2026-03-28 20:54
Core Viewpoint - The Home Depot, Inc. (NYSE:HD) is viewed positively by analysts following its acquisition of Mingledorff's, which is expected to significantly enhance the company's market position and growth potential in the HVAC distribution sector [2][3]. Group 1: Analyst Insights - Jefferies analysts express confidence in the acquisition of Mingledorff's, projecting an expansion of the combined Total Addressable Market (TAM) by $100 billion [2]. - The acquisition is anticipated to strengthen The Home Depot's long-term earnings power and growth narrative in the HVAC distribution vertical [2]. - BNP Paribas has adjusted its valuation model, lowering the target multiple from 19.5x to 17.5x EV/EBIT due to market conditions, while still supporting the acquisition as a strategic move [3]. Group 2: Ratings and Price Targets - Jefferies maintains a "Buy" rating on The Home Depot stock following the acquisition announcement [2]. - BNP Paribas has a "Neutral" rating on the stock and has reduced its price target from $391 to $348 [4].
Jim Cramer on Cardinal Health: “I Want You to Buy It and Buy It, Get This, Aggressively”
Yahoo Finance· 2026-03-27 18:01
Group 1 - Cardinal Health, Inc. (NYSE:CAH) is recognized for supplying branded, generic, and specialty medicines, as well as providing pharmacy and specialty drug services [2] - The company also manufactures and distributes medical and surgical products and procedure kits, indicating a diverse product portfolio [2] - Jim Cramer expressed strong confidence in Cardinal Health, suggesting that the stock could reach $300, highlighting the positive impact of recent acquisitions [2] Group 2 - Cramer acknowledged that while Cardinal Health has potential, certain AI stocks may offer greater upside potential and less downside risk [3] - The mention of AI stocks indicates a competitive landscape where Cardinal Health is being compared to emerging technology sectors [3]
Raymond James Maintains a Market Perform Rating on Whirlpool (WHR)
Yahoo Finance· 2026-03-27 11:31
Group 1 - Whirlpool Corporation (NYSE:WHR) is identified as one of the heavily-battered consumer stocks that could potentially triple by 2027 [1] - Major appliance industrial production is reported to be down 7% year over year through February, with daily AHAM data estimated down 4%-6% for the same period, indicating that Q1 industry production and wholesale shipments are tracking below Whirlpool's expectations [2] - JPMorgan analyst Michael Rehaut has lowered the price target for Whirlpool Corporation to $59 from $76 and maintained a Neutral rating, while also reducing earnings estimates for 2026 and 2027 [3] Group 2 - Stifel has also reduced its price target on Whirlpool Corporation to $68 from $75, maintaining a Hold rating and adjusting estimates for dilution following the company's offering of common equity and depository shares, now estimating FY26 EPS at $6.00 [5] - The company manufactures and markets home appliances and related products and services globally, but certain AI stocks are noted to offer greater upside potential with less downside risk [6]
Stifel Maintains a Hold Rating on Revvity (RVTY)
Yahoo Finance· 2026-03-27 07:29
Core Viewpoint - Revvity, Inc. (NYSE:RVTY) is identified as one of the best mid-cap value stocks to buy in 2026, with a Hold rating maintained by Stifel and a price target of $110 [1]. Group 1: Management Insights - Management expressed cautious optimism regarding certain business segments and the end market, with 2026 guidance assuming a steady-state environment and low-single digit growth in pharma and biotech, similar to 2025 [2]. - Positive indicators highlighted by management include increased activity in high-content screening, improved biotech funding, and ongoing mergers and acquisitions in pharma and biotech [2]. Group 2: Market Challenges - The cautious outlook is attributed to weak academic demand and short-term organic growth headwinds, including reduced demand from China and slower on-premises software renewals [4]. - 2026 is viewed as a pivotal year for Revvity, with potential macro-economic recovery or acceleration in biotech funding seen as drivers for upside [4]. Group 3: Company Overview - Revvity, Inc. offers advanced health science solutions across various segments, including multi-omics, imaging, biomarkers, and informatics [4].
Northrop Grumman (NOC) Stock Up After Jim Cramer Said It Could Be Bought
Yahoo Finance· 2026-03-26 18:34
Core Viewpoint - Northrop Grumman Corporation (NYSE:NOC) is highlighted as a strong defense technology stock, with significant recent performance and strategic insights from Jim Cramer [1]. Group 1: Company Performance - Northrop Grumman's shares have increased by 37% over the past year and by 25% since being discussed by Cramer on Mad Money [1]. - The company's shares closed 12.7% lower on April 22, 2025, following a fiscal first quarter earnings report that revealed a profit per share of $6.06, which fell short of analyst expectations of $6.26 [1]. - The firm has adjusted its annual profit per share guidance down to a range of $24.95 to $25.35, from a previous estimate of $27.85 to $28.25, due to losses incurred on the B-21 stealth bomber program [1]. Group 2: Market Context - Following the initiation of U.S. military operations in Iran, Northrop Grumman's shares rose by 6% on March 2, 2025 [1]. - Cramer expressed optimism about defense stocks, suggesting that increased military spending could be a response to geopolitical pressures, indicating a favorable outlook for Northrop Grumman and similar companies [1].
Carnival Corp. (CCL) Upgraded by Morgan Stanley
Yahoo Finance· 2026-03-26 05:55
Core Viewpoint - Carnival Corporation & plc (NYSE: CCL) is identified as a large-cap stock under $30 with significant upside potential, with analysts adjusting their ratings and target prices reflecting current market conditions [1][4]. Group 1: Analyst Ratings and Target Prices - Jamie Rollo from Morgan Stanley upgraded Carnival's rating from Equal Weight to Overweight, reducing the target price from $33 to $31, indicating an adjusted upside potential of nearly 22% [1]. - Lizzie Dove from Goldman Sachs lowered the target price from $34 to $30 while maintaining a Buy rating, suggesting an upside potential of almost 18% despite the adjustment [4]. Group 2: Earnings Estimates and Market Conditions - Rollo reduced earnings estimates due to softer revenue yield and increased fuel costs, noting that the stock's 28% year-to-date decline already reflects these pressures [3]. - Dove highlighted that a 50% increase in heavy fuel oil and marine petrol oil prices would lead to an expected EPS headwind of 6 cents in Q1 and 31 cents for FY26, translating to an approximate $430 million EBITDA effect [5]. Group 3: Company Overview - Carnival Corporation operates various travel services under multiple brands, including Seabourn, Carnival Cruise Line, Princess Cruises, Cunard, Holland America Line, and P&O Cruises, and manages several islands, hotels, and port destinations [6].
DA Davidson Cuts PT on Huntington Bancshares (HBAN) to $20 From $21 – Here’s Why
Yahoo Finance· 2026-03-25 19:08
Huntington Bancshares Incorporated (NASDAQ:HBAN) is one of the best undervalued stocks under $50 to invest in now. On March 16, DA Davidson cut the price target on Huntington Bancshares Incorporated (NASDAQ:HBAN) to $20 from $21 and reiterated a Buy rating on the shares. The firm told investors in a research note that although the stock has underperformed year-to-date and provided some execution risk of integrating two acquisitions, the management team boasts a proven track record on bank integrations. Tr ...